Novel molecular markers of lung cancer risk and survival [ 2013 - ]

Research Grant

Researchers: Dr Allison Hodge (Principal investigator) ,  Dr Gianluca Severi (Principal investigator) ,  Dr Mattias Johansson

Brief description Lung cancer remains the most lethal cancer worldwide, yet little is known of the risk factors beyond that of tobacco smoking and certain occupational exposures. We have assembled a large international consortium comprising 24 cohort studies and over 10,000 to validate associations between B-vitamins and lung cancer risk particularly in never and former smokers. We propose to expand this study and use the Melbourne Collaborative Cohort Study and the rest of the consortium to identify novel biomarkers of risk and survival.

Funding Amount $824,765.00

Funding Scheme Project Grants

Notes Standard Project Grant